Lynen, Nils A.
Eichhorn, Christoph
Portelange, Nicolas http://orcid.org/0009-0005-5420-0571
Chausson, Mickaël
Weyenberg, Wim
Clinical trials referenced in this document:
Documents that mention this clinical trial
Long-Term Efficacy Following Intra-articular Injection of Carboxymethyl-chitosan, a New Product Class for Knee Osteoarthritis: Results from an Observational Study in Germany
https://doi.org/10.1007/s40744-024-00661-6
Funding for this research was provided by:
KiOmed Pharma
Article History
Received: 25 January 2024
Accepted: 29 February 2024
First Online: 18 March 2024
Declarations
:
: Nicolas Portelange, Mickael Chausson and Wim Weyenberg are employees for KiOmed Pharma, Herstal, Belgium. Nils Lynen and Christoph Eichhorn have nothing to disclose.
: This study was carried out in accordance with ethical principles that have their origin in the Declaration of Helsinki adopted by the 18th World Medical Assembly in Helsinki (Finland) since 1964, as last amended by the World Medical Assembly. Furthermore, the study was carried out in accordance with the principles of good clinical practice (GCP) outlined in ISO 14155:2020 “Clinical investigation of medical devices for human subjects—Good Clinical Practice”. The study started following a positive advisory opinion of the responsible ethics committee (reference “2020402”, Ethikkommission der Äerztekammer.